As of 2025-05-22, the Net Margin of SymBio Pharmaceuticals Ltd (4582.T) is -156.3%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -156.3% |
2023-12-31 | -35.1% |
2022-12-31 | 11.8% |
2021-12-31 | 24.6% |
2020-12-31 | -136.9% |
2019-12-31 | -154.2% |
2018-12-31 | -71.8% |
2017-12-31 | -115.5% |
2016-12-31 | -97.7% |
2015-12-31 | -136.1% |